An AMCP LINK Webinar.

As 2026 begins, prior authorization and utilization management remain at the center of payer strategy and regulatory scrutiny. This Prior Authorization and Utilization Management LINKs kickoff webinar will explore the current policy landscape - what's changing, what's proposed, and what it means for your daily work. This will be a discussion-forward session focused on:

• The State of Play
• Disconnects and Realities
• Operational Impacts

Join us to share insights, surface pain points, and help shape AMCP's advocacy and practice agenda for 2026. Your voice will guide where policy meets practice.

Join AMCP Government Affairs staff for a look at anticipated legislation and regulation in 2026 that will impact the practice of managed care pharmacy. Important issues being debated by lawmakers this year include pharmacy benefit manager reform, most-favored-nation drug pricing, direct-to-consumer drug sales, 340B reform, and more. The Government Affairs team will also discuss the government funding package to be passed by January 31 and health care implications of the Congressional midterm elections.

Hello Precision Medicine Enthusiasts!

Join us for our upcoming LINK call, where we’ll explore the real-world impact of clinical utility in precision medicine. We’ll kick things off with a quick, lively overview— to get us thinking about “how does this help patients and providers?”

After the intro, we’ll break out into working groups to tackle some of the most important questions in clinical utility. We can't wait to hear your ideas!

Breakout 1: Defining and Measuring Clinical Utility

Breakout 2: Payer and Policy Considerations

Breakout 3: Operationalizing Clinical Utility in Practice

A Science & Innovation Webinar, presented by Abbvie.

One of the primary goals of acute treatment of migraine is rapid and consistent freedom from pain and associated symptoms without recurrence. Regardless of migraine frequency or time of month, it is important that every appropriate person with migraine be offered a migraine-specific treatment. The objective for this webinar is to review the migraine disease state and outline the clinical data for an acute treatment of migraine including data for perimenstrual attacks.

A Science & Innovation Webinar, presented by Abbvie.

Vitiligo is more than a cosmetic concern. It is a chronic, autoimmune disease characterized by the progressive loss of melanocytes, leading to depigmented patches on the skin—the body’s most visible and socially expressive organ. NSV reflects underlying immune dysregulation and can be associated with systemic comorbidities such as autoimmune thyroid disease, type 1 diabetes, pernicious anemia, and alopecia areata. Beyond the physical manifestations, NSV carries a profound psychological burden, with increased rates of anxiety, depression, and social withdrawal. These interconnected challenges not only affect patient quality of life but also contribute to broader healthcare utilization and underscore the need for holistic, long-term management strategies.

An AMCP Member Webinar